Montelukast for the treatment of asthma in the adult population

Expert Opinion on Pharmacotherapy

Volumn 12, Issue 13, 2011, Pages 2119-2128

  Amlani, Salima ^a   Nadarajah, Thanu ^a   McIvor, Richard Andrew ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

asthma; leukotriene receptor antagonists; montelukast

Indexed keywords

BECLOMETASONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DIGOXIN; FLUTICASONE; IMMUNOGLOBULIN E ANTIBODY; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; PHENYTOIN; PLACEBO; SALMETEROL; STEROID; THEOPHYLLINE; WARFARIN; ZAFIRLUKAST;

ABDOMINAL PAIN; ADD ON THERAPY; ADULT; AGGRESSION; ALLERGIC RHINITIS; ASTHMA; CHURG STRAUSS SYNDROME; COUGHING; DEPRESSION; DISEASE EXACERBATION; DRUG ABSORPTION; DRUG ANTAGONISM; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG MEGADOSE; DRUG METABOLISM; DRUG SAFETY; DRUG STRUCTURE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPHONIA; EAR INFECTION; FORCED EXPIRATORY VOLUME; HALLUCINATION; HUMAN; IMMUNOTHERAPY; INSOMNIA; LOW DRUG DOSE; MAXIMUM PLASMA CONCENTRATION; MONOTHERAPY; NAUSEA; OROPHARYNX CANDIDIASIS; PHARYNGITIS; POSTMARKETING SURVEILLANCE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIDE EFFECT; SUICIDAL IDEATION; SUICIDE; TERATOGENICITY; TREATMENT RESPONSE;

ACETATES; ADULT; ANIMALS; ANTI-INFLAMMATORY AGENTS; ASTHMA; CLINICAL TRIALS AS TOPIC; HUMANS; QUINOLINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 80051491390     PISSN: 14656566     EISSN: 17447666     Source Type: Journal    
DOI: 10.1517/14656566.2011.600689     Document Type: Review

References (65)

1. Lewis RA, Austen KF, Soberman RJ. Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N Engl J Med 1990;323:645-55 (Pubitemid 20280195)
2. Holgate ST, Frew AJ. Choosing therapy for childhood asthma. N Engl J Med 1997;337:1690-2 (Pubitemid 27510111)
3. Lougheed DM, Lemiere C, Dell SD, et al. Canadian Thoracic Society Asthma Continuum - 2010 consensus summary for children six years of age and over, and adults. Can Respir J 2010;17:15-24
4. Masoli M, Fabian D, Holt S, et al. The global burden of asthma: Executive summary of the GINA dissemination committee report. Allergy 2004;59:469-78 (Pubitemid 38580764)
5. Benninger MS, Waters H. Montelukast: Pharmacology, safety, tolerability and efficacy. Clin Med Ther 2009;1:1253-61
6. Pawankar R. Allergic rhinitis and asthma: The link, the new ARIA classification and global approaches to treatment. Curr Opin All Clin Immunol 2004;4(1):1-4 (Pubitemid 39090046)
7. Guerra S, Sherrill DL, Martinez FD, et al. Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol 2002;109(3):419-25 (Pubitemid 34234190)
8. British Thoracic Society. British guideline on the management of asthma. Thorax 2008;63(4):1-121
9. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008;31(1):143-78
10. Peters SP, Kunselman SJ, Icitovic N, et al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med 2010;363:1715-26
11. Cox G, Thomson NC, Rubin AS, et al. Asthma control during the year after bronchial thermoplasty. N Engl J Med 2007;356:1327-37 (Pubitemid 46513298)
12. Merck Frosst Canada. (2011). Research & Development: Major Accomplishments: Singulair. Available from: Http://www.merckfrosst.ca/mfcl/en/ corporate/research/accomplishments/ singulair. html
13. Walia M, Lodha R, Kabra SK. Montelukast in pediatric asthma management. Indian J Pediatr 2006;73(4):276-82
14. Cheng H, Leff JA, Amin R, et al. Pharmacokinetics, bioavailability and safety of montelukast sodium (MK-0476) in healthy males and females. Pharm Res 1996;13:445-8 (Pubitemid 26114730)
15. Bjermer L, Bisgaard H, Bousquet J, et al. Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: One year, double blind, randomised, comparative trial. BMJ 2003;327:891-7
16. Braccioni F, Dorman SC, O'Byrne PM, et al. The effect of cysteinyl leukotrienes on growth of eosinophil progenitors from peripheral blood and bone marrow of atopic subjects. J Allergy Clin Immunol 2002;110(1):96-101 (Pubitemid 36132734)
17. Laviolette M, Malmstrom K, Lu S, et al. Montelukast added to inhaled beclomethasone in treatment of asthma. Am J Respir Crit Care Med 1999;160(6):1862-8 (Pubitemid 30004688)
18. Vaquerizo MJ, Casan P, Castillo J, et al. Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma. Thorax 2003;58(3):204-10 (Pubitemid 36307997)
19. Price DB, Hernandez D, Magyar P, et al. Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma. Thorax 2003;8(3):211-16 (Pubitemid 36307998)
20. Lofdahl CG, Reiss TF, Leff JA, et al. Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients. BMJ 1999;319(7202):87-90 (Pubitemid 29313237)
21. Tohda Y, Fujimura M, Taniguchi H, et al. Leukotriene receptor antagonist, montelukast, can reduce the need for inhaled steroid while maintaining the clinical stability of asthmatic patients. Clin Exp Allergy 2002;32(8):1180-6 (Pubitemid 35007421)
22. Ducharme FM, Hicks GC. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children. Cochrane Database Syst Rev 2002;(3):CD002314
23. Nelson HS, Busse WW, Kerwin E, et al. Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast. J Allergy Clin Immunol 2000;106(6):1088-95 (Pubitemid 32006262)
24. Fish JE, Israel E, Murray JJ, et al. Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy. Chest 2001;120(2):423-30 (Pubitemid 32881257)
25. Ringdal N, Eliraz A, Pruzinec R, et al. The salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthma. Respir Med 2003;97(3):234-41 (Pubitemid 36266879)
26. Ilowite J, Webb R, Friedman B, et al. Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: A randomized, double-blind, multicenter study. Ann Allergy Asthma Immunol 2004;92(6):641-8 (Pubitemid 39243154)
27. Bjermer L, Bisgaard H, Bousquet J, et al. Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: One year, double blind, randomised, comparative trial. BMJ 2003;327(7420):891
28. Joos S, Miksch A, Szecsenyi J, et al. Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: A systematic review. Thorax 2008;63(5):453-62 (Pubitemid 351698876)
29. McIvor RA, Pizzichini E, Turner MO, et al. Potential masking effects of salmeterol on airway inflammation in asthma. Am J Respir Crit Care Med 1998;158(3):924-30 (Pubitemid 28449462)
30. Salpeter SR, Buckley NS, Ormiston TM, et al. Meta-analysis: Effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths. Ann Intern Med 2006;144(12):904-12 (Pubitemid 46768131)
31. Ducharme FM, Ni Chroinin M, Greenstone I, et al. Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children. Cochrane Database Syst Rev 2010;(5):CD005535
32. Ducharme FM, Ni Chroinin M, Greenstone I, et al. Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma. Cochrane Database Syst Rev 2010;(4):CD005533
33. Ernst P, McIvor A, Ducharme FM, et al. Safety and effectiveness of long-acting inhaled beta-agonist bronchodilators when taken with inhaled corticosteroids. Ann Intern Med 2006;145(9):692-4 (Pubitemid 46768845)
34. Philip G, Nayak AS, Berger WE, et al. The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis. Curr Med Res Opin 2004;20(10):1549-58 (Pubitemid 39457543)
35. Vignola AM, Chanez P, Bousquet J. The relationship between asthma and allergic rhinitis: Exploring the basis for a common pathophysiology. Clin Exp Allergy Rev 2003;3:63-8 (Pubitemid 36528936)
36. Bourdin A, Gras D, Vachier I, Chanez P. Upper airway x 1: Allergic rhinitis and asthma: United disease through epithelial cells. Thorax 2009;64(11):999-1004
37. Braunstahl GJ, Overbeek SE, Fokkens WJ, et al. Segmental bronchoprovocation in allergic rhinitis patients affects mast cell and basophil numbers in nasal and bronchial mucosa. Am J Respir Crit Care Med 2001;164:858-65 (Pubitemid 32881925)
38. Passalacqua G, Ciprandi G, Canonica GW. United airways disease: Therapeutic aspects. Thorax 2000;55:S26-7
39. Greisner WA, Settipane RJ, Settipane GA. Co-existence of asthma and allergic rhnitis: A 23-year follow-up study of college students. Allergy Asthma Proc 1998;19(4):185-8 (Pubitemid 128684482)
40. Moller C, Dreborg S, Ferdousi HA, et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PATstudy). J Allergy Clin Immunol 2002;109:251-6 (Pubitemid 34158289)
41. Price D, Zhang Q, Kocevar VS, et al. Effect of a concomitant diagnosis of allergic rhinitis on asthma-related health care use by adults. Clin Exp Allergy 2005;35:282-7 (Pubitemid 40516652)
42. Busse WW, Casale TB, Dykewicz MS, et al. Efficacy of montelukast during the allergy season in patients with chronic asthma and seasonal aeroallergen sensitivity. Ann Allergy Asthma Immunol 2006;96:60-8 (Pubitemid 43152669)
43. Price DB, Swern A, Tozzi CA, et al. Effect of montelukast on lung function in asthma patients with allergic rhinitis: Analysis from the COMPACT trial. Allergy 2006;61(6):737-42 (Pubitemid 43801409)
44. Virchow JC, Bachert C. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis. Respir Med 2006;100(11):1952-9 (Pubitemid 44490289)
45. Keith PK, Koch C, Djandji M, et al. Montelukast as add-on therapy with inhaled corticosteroids or inhaled corticosteroids and long acting beta-2-agonist in the management of patients diagnosed with asthma and concurrent allergic rhinitis (the RADAR trial). Can Respir J 2009;16(Suppl A):17A-31A
46. McIvor RA, Sampalis J. Real-life asthma care in Canada. Can Respir J 2009;16(Suppl A):3A-6A
47. Herland K, Akselsen JP, Skjonsberg OH, et al. How representative are clinical study patients with asthma or COPD for a larger 'real life' population of patients with obstructive lung disease? Respir Med 2005;99:11-19 (Pubitemid 40017378)
48. Dupont L, Potvin E, Korn D. Improving asthma control in patients suboptimally controlled on inhaled steroids and long acting beta agonists: The addition of montelukast in an open-label pilot study. Curr Med Res Opin 2005;21(6):863-942
49. Korn D, Van den Brande D, Potvin E, et al. Efficacy of add-on montelukast in patients with non-controlled asthma: A Belgian open label study. Curr Med Res Opin 2009;25(2):489-97
50. FitzGerald JM, Foucart S, Coyle S, et al. Montelukast as add-on therapy to inhaled corticosteroids in the management of asthma (SAS trial). Can Respir J 2009;16(Suppl A):5A-14A
51. Virchow JC, Mehta A, Ljungblad L, Mitfessel H. Add-on montelukast in inadequately controlled asthma patients in a 6 month open label study: The montelukast in chronic asthma (MONICA) study. Respir Med 2010;104(5):644-51
52. Schlick W, Pohl W, Pfeiffer KP, et al. Evaluation of 3-5 months' add-on therapy with montelukast in patients with non-controlled asthma in Austria: The STAR open-label, real world, observational study. Curr Med Res Opin 2010;26(3):561-70
53. McIvor RA, Kaplan A, Koch C, et al. Montelukast as an alternative to low-dose inhaled corticosteroids in the management of asthma (SIMPLE trial). Can Respir J 2009;16(Suppl A):5A-14A
54. Riccioni G, Bucciarelli T, Mancini B, et al. Antileukotriene drugs: Clinical application, effectiveness and safety. Curr Med Chem 2007;14:1966-77 (Pubitemid 47209107)
55. Echsler ME, Finn D, Gunawardena D, et al. Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma. Chest 2000;117:708-13 (Pubitemid 30152209)
56. S Bibby S, Healy B, Steele R, et al. Association between leukotriene receptor antagonist therapy and Churg-Strauss syndrome: An analysis of the FDA AERS database. Thorax 2010;65:132-8
57. Diamant Z, Mantzouranis E, Bjermer L. Montelukast in the treatment of asthma and beyond. Expert Rev Clin Immunol 2009;5(6):639-58
58. US Food and Drug Administration. (2010). Updated information on leukotriene inhibitors. Available from: Http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationfor PatientsandProviders/ DrugSafetyInformationforHeathcare Professionals/ucm165489.htm
59. Manalai P, Woo JM, Postolache TT. Suicidality and montelukast. Expert Opin Drug Saf 2009;8:273-82
60. Majid H, Kao C. Utility of exhaled nitric oxide in the diagnosis and management of asthma. Curr Opin Pulm Med 2010;16(1):42-7
61. Van Adelsberg J, Moy J, Wei LX, et al. Safety, tolerability, and exploratory efficacy of montelukast in 6- to 24-month-old patients with asthma. Curr Med Res Opin 2005;21(6):971-9
62. Philip G, Pedinoff A, Vandormael K, et al. A phase I randomized, placebo-controlled, dose-exploration study of single-dose inhaled montelukast in patients with chronic asthma. J Asthma 2010;47(10):1078-84
63. Morris CR, Becker AB, Pinieiro A, et al. A randomized, placebo-controlled study of intravenous montelukast in children with acute asthma. Ann Allergy Asthma Immunol 2010;104(2):161-71
64. Camargo CA Jr, Gurner DM, Smithline HA, et al. A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma. J Allergy Clin Immunol 2010;125(2):374-80
65. DuBuske LM, Grossman J, Dube LM, et al. Randomized trial of zileuton in patients with moderate asthma: Effect of reduced dosing frequency and amounts on pulmonary function and asthma symptoms. Am J Manag Care 1997;3(4):633-40 (Pubitemid 127528789)